Abiopharma

Smoothie King Drives Incremental Revenue and Loyalty Engagement with PAR Games in First Three Months

Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE® (tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Ieda Gomes Yell

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Jan Holm

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Yap Chee Keong

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Interest of Director - Mark Gainsborough

Employee Stock Option/ Share Scheme: Grant of Awards and Transfer and Use of Treasury Shares

Core & Main Announces Fiscal 2026 First Quarter Results

New Form 11-K - FULLER H B CO <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001437749-26-020091 <b>Size:</b> 2 MB

Clearwater Analytics將因子風險統一納入投資組合管理與風險監督

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001918704-26-016210 <b>Size:</b> 633 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001918704-26-016209 <b>Size:</b> 1 MB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001918704-26-016208 <b>Size:</b> 1 MB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-06-10 <b>AccNo:</b> 0001918704-26-016207 <b>Size:</b> 1 MB

ACCENTURE : ÉTUDE CONSUMER PULSE 2026 – FRANCE